PROCTER & GAMBLE HEALTH
|
The Current P/B Ratio of PROCTER & GAMBLE HEALTH is 10.48.
Share Price | ₹4,692.8 | Apr 18,2024 |
Market Cap | ₹7,790.0 Cr | |
Book Value | ₹743.1 Cr | Jun2023 - Standalone Results |
Price/Book | 10.48x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of PROCTER & GAMBLE HEALTH
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹7,790.0 Cr] as on Apr 18,2024
(/) Book Value [ ₹743.1 Cr] based on Jun2023 - Standalone Results
(=) P/B Ratio [ 10.48x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '10.48 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/B Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PB (Price/Book ) ratio chart of PROCTER & GAMBLE HEALTH
PB Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/b ratio for fiscal years ending Jun2023 to Dec2018 averaged 9.44x.
- PROCTER & GAMBLE HEALTH 's operated at median p/b ratio of 11.41x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/b ratio peaked in Jun2021 at 13.27x.
- PROCTER & GAMBLE HEALTH 's p/b ratio hit its five-year low in Dec2018 of 3.32x.
How does PROCTER & GAMBLE HEALTH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
PROCTER & GAMBLE HEALTH | 743.05 | 10.48 | 7,790.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 55,995.40 | 6.50 | 364,015.0 |
CIPLA LTD | 23,346.00 | 4.66 | 108,809.0 |
DR REDDYS LABORATORIES LTD | 23,140.40 | 4.30 | 99,408.7 |
ZYDUS LIFESCIENCES LTD | 17,515.80 | 5.38 | 94,213.7 |
DIVIS LABORATORIES LTD | 12,767.10 | 7.73 | 98,684.0 |
MANKIND PHARMA LTD | 7,435.16 | 12.92 | 96,037.1 |
TORRENT PHARMACEUTICALS LTD | 6,198.07 | 13.91 | 86,219.0 |
LUPIN LTD | 12,315.60 | 5.90 | 72,621.1 |
AUROBINDO PHARMA LTD | 26,839.80 | 2.43 | 65,326.3 |
ABBOTT INDIA LTD | 3,146.02 | 17.60 | 55,366.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PROCTER & GAMBLE HEALTH 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.43x |
Max industry PB | 17.60x |
Median industry PB | 6.50x |
Average industry PB | 8.35x |
You may also like the below Video Courses